A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer

NCT06266143 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Adenocarcinoma

Interventions

DRUG: Y101D

Sponsor

Wuhan YZY Biopharma Co., Ltd.